KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cash from Financing Activities (2016 - 2025)

Charles River Laboratories International has reported Cash from Financing Activities over the past 17 years, most recently at -$51.9 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 31.65% year-over-year to -$51.9 million; the TTM value through Dec 2025 reached -$536.7 million, up 2.58%, while the annual FY2025 figure was -$536.7 million, 2.58% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$51.9 million at Charles River Laboratories International, up from -$152.6 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $518.0 million in Q2 2021 and troughed at -$285.9 million in Q2 2024.
  • A 5-year average of -$27.1 million and a median of -$61.7 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: soared 597.57% in 2021 and later crashed 674.1% in 2025.
  • Year by year, Cash from Financing Activities stood at -$219.0 million in 2021, then fell by 13.69% to -$249.0 million in 2022, then soared by 149.63% to $123.6 million in 2023, then tumbled by 161.41% to -$75.9 million in 2024, then surged by 31.65% to -$51.9 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CRL at -$51.9 million in Q4 2025, -$152.6 million in Q3 2025, and -$226.9 million in Q2 2025.